Ultra-Low-Dose Rituximab in Pemphigus Vulgaris: How Low is the Lowest?

Ultra-Low-Dose Rituximab in Pemphigus Vulgaris: How Low is the Lowest?

Saved in:

Bibliographic Details
Main Authors:	Nayankumar H. Patel, Jignaben K. Padhiyar
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-07-01
Series:	Indian Dermatology Online Journal
Online Access:	https://journals.lww.com/10.4103/idoj.idoj_1266_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The efficacy and safety of low-dose rituximab in the treatment of pemphigus vulgaris: a cohort study
by: Xingli Zhou, et al.
Published: (2024-12-01)

Paraneoplastic Pemphigus Presenting as Toxic Epidermal Necrolysis: A Case Report
by: Jignaben K Padhiyar, et al.
Published: (2018-03-01)

Paraneoplastic Pemphigus Presenting as Toxic Epidermal Necrolysis: A Case Report
by: Jignaben K Padhiyar, et al.
Published: (2018-03-01)

Efficacy and safety of low dose rituximab in pemphigus: an updated systematic review and meta-analysis
by: Si-Han Liu, et al.
Published: (2025-07-01)

Rituximab in the Management of a Child with Pemphigus Vulgaris: Case Study
by: Nikolay N. Murashkin, et al.
Published: (2022-11-01)

Low Dose Vs Conventional Rituximab Regimen in Pemphigus Vulgaris – A Retrospective Single Centre Comparative Analysis to Assess the Clinical Efficacy and Cost-Effectiveness
by: Amuthavalli Kanagarajan, et al.
Published: (2025-07-01)

A Rare Case of Late Infantile Form of Multiple Sulfatase Deficiency
by: Megha P. Lakum, et al.
Published: (2024-10-01)

Targeted Immunotherapy with Rituximab Leads to a Transient Alteration of the IgG Autoantibody Profile in Pemphigus Vulgaris
by: Ralf Müller, et al.
Published: (2010-01-01)

Pediatric pemphigus herpetiformis treated with rituximab
by: Mira Hamed, MD, et al.
Published: (2024-12-01)

Is Latent Syphilis New Normal among Clinical Presentations of Syphilis? Study from a Tertiary Care Institute
by: Jignaben Krunal Padhiyar, et al.
Published: (2019-03-01)

Is Latent Syphilis New Normal among Clinical Presentations of Syphilis? Study from a Tertiary Care Institute
by: Jignaben Krunal Padhiyar, et al.
Published: (2019-03-01)

Koebner’s Phenomenon in Pemphigus Vulgaris
by: Anand Mannu, et al.
Published: (2025-03-01)

Pemphigus Vulgaris in Old Patient
by: Bassel Tarakji
Published: (2021-01-01)

Effectiveness of rituximab in the treatment of patients with pemphigus vulgarus
by: Arfenya E. Karamova, et al.
Published: (2024-11-01)

Treatment of refractory pemphigus vulgaris with efgartigimod
by: Matthew Helm, MD, et al.
Published: (2025-07-01)

Characteristics and management of pediatric pemphigus vulgaris
by: LIANG Wenhui, CHEN Yuting, DAN Hongxia
Published: (2025-07-01)

A case of umbilical pemphigus vulgaris
by: ZHENG Hang, et al.
Published: (2024-11-01)

Ultra-low-dose rituximab is effective for the treatment of patients with minimal change disease - A retrospective study
by: Chang Wang, et al.
Published: (2025-07-01)

Rituximab in Pemphigus - Exploring the Less Frequently Travelled Terrains
by: Raghavendra Rao
Published: (2025-07-01)

Single-agent rituximab and ultra-low-dose adaptive radiotherapy for the treatment of indolent B-cell non-Hodgkin lymphomas
by: Katherine E. Lake, et al.
Published: (2025-07-01)

The big decline: Lowest-low fertility in Uruguay (2016–2021)
by: Wanda Cabella, et al.
Published: (2024-03-01)

Scrotal Tongue in Juvenile Oral Pemphigus Vulgaris
by: Shruthi Madhavi Govindarajulu, et al.
Published: (2025-07-01)

Oral Lesions: The Clue to Diagnosis of Pemphigus Vulgaris
by: Diana Kuriachan, et al.
Published: (2015-01-01)

Koebner phenomenon in a severe pemphigus vulgaris
by: Nunzia Di Cristo, et al.
Published: (2025-01-01)

Lowest-Low Fertility in Japan: Consequences For A Once-Great Nation
by: Sutton Michael
Published: (2009-01-01)

Combination Therapy With Rituximab and Low-Dose Cyclophosphamide and Prednisone in Membranous Nephropathy
by: Coralien H. Vink, et al.
Published: (2024-12-01)

Pemphigus Vulgaris Confined to the Gingiva: A Case Report
by: Mitsuhiro Ohta, et al.
Published: (2011-01-01)

Multiple Conjunctival Papillomas of Eyelid Margins in Pemphigus vulgaris
by: Inbal Avisar, et al.
Published: (2011-01-01)

Clinical outcomes and prognostic factors of pemphigus vulgaris and pemphigus foliaceus: A 20-year retrospective study
by: Hongda Li, et al.
Published: (2025-05-01)

Ultra-low dose immunoPET using 64Cu-rituximab tracer for a human CD20 mouse model
by: Frezghi Habte, et al.
Published: (2025-04-01)

Assessment of Efficacy of Adjuvant Topical Rituximab Encapsulated in Nanoparticle Gel in Oral Pemphigus Vulgaris: A Randomized, Double-Blind, Placebo-Controlled, Pilot Study
by: Pratik Rajendra Mohta, et al.
Published: (2025-07-01)

Ofatumumab for the management of refractory pemphigus vulgaris: A case series
by: Sera Sarsam, MBBS, BMedSc, et al.
Published: (2025-10-01)

Management of painful pemphigus vulgaris – Relieving pain and restoring dignity
by: Naveen Malhotra, et al.
Published: (2025-01-01)

Erythema multiforme secondary to filgrastim in a case of pemphigus vulgaris
by: Prachi Bhandare, et al.
Published: (2025-01-01)

Conjoint analysis of methylation, transcriptomic, and proteomic profiles in pemphigus vulgaris
by: Xiaojia Luo, et al.
Published: (2024-11-01)

Analysis of laboratory parameters in patients with pemphigus vulgaris complicated with infections
by: ZHAO Shiqi, et al.
Published: (2025-04-01)

Endoscopic Findings of Mucosal Pemphigus Vulgaris: Clinical Correlation and Diagnostic Value
by: Zeynep Karaca Ural, et al.
Published: (2025-07-01)

Role of Desmoglein Autoantibody in the Diagnosis of Pemphigus Vulgaris: A Case Report
by: Diane Lukito Setiawan, et al.
Published: (2025-07-01)

Coexistence of Pemphigus Vulgaris and Lichen Planus following COVID-19 Vaccination
by: Zeinab Aryanian, et al.
Published: (2022-01-01)

Simultaneous Oral and Umbilical Locations as a First Sign of Pemphigus Vulgaris
by: Eya Moussaoui, et al.
Published: (2021-01-01)